Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease

Show other versions (1)

Huntington disease (HD) is a devastating, late-onset, inherited neurodegenerative disorder that manifests with personality changes, movement disorders, and cognitive decline. It is caused by a CAG repeat expansion in exon 1 of the HTT gene that translates to a polyglutamine tract in the huntingtin p...

Full description

Bibliographic Details
Main Authors:	Sathasivam, Kirupa, Neueder, Andreas, Landles, Christian, Benjamin, Agnesska C., Bondulich, Marie K., Amith, Donna L., Faull, Richard L. M., Roos, Raymund A. C., Howland, David, Detloff, Peter J., Bates, Gillian P., Housman, David E, Wasylenko, Theresa Anne
Other Authors:	Massachusetts Institute of Technology. Department of Biology
Format:	Article
Language:	en_US
Published:	National Academy of Sciences (U.S.) 2013
Online Access:	http://hdl.handle.net/1721.1/79814 https://orcid.org/0000-0002-0524-5301 https://orcid.org/0000-0001-5016-0756

Similar Items

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
by: Andreas Neueder, et al.
Published: (2017-05-01)

Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
by: Franziska Hoschek, et al.
Published: (2024-03-01)

Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
by: Franziska Hoschek, et al.
Published: (2024-04-01)

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
by: Michael A. Mason, et al.
Published: (2020-08-01)

HSF1-dependent and -independent regulation of the mammalian in vivo heat shock response and its impairment in Huntington's disease mouse models
by: Neueder, Andreas, et al.
Published: (2018)

Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease
by: Ya Zhou, et al.
Published: (2021-04-01)

Parkinsonism with a Hint of Huntington’s from 29 CAG Repeats in HTT
by: Sipilä JOT
Published: (2019-09-01)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
by: Aleksandra S. Taran, et al.
Published: (2020-06-01)

A novel and accurate full-length HTT mouse model for Huntington’s disease
by: Sushila A Shenoy, et al.
Published: (2022-01-01)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
by: Harleen Kohli, et al.
Published: (2021-02-01)

Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.
by: Michal Mielcarek, et al.
Published: (2014-08-01)

Huntington's disease: a clinical review
by: Roos Raymund AC
Published: (2010-12-01)

Regulatory mechanisms of incomplete huntingtin mRNA splicing
by: Andreas Neueder, et al.
Published: (2018-09-01)

Reduction in PA28αβ activation in HD mouse brain correlates to increased mHTT aggregation in cell models.
by: Karlijne W Geijtenbeek, et al.
Published: (2022-01-01)

Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington’s Disease
by: Laura Gantley, et al.
Published: (2023-05-01)

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
by: Lulin Huang, et al.
Published: (2022-03-01)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
by: Marie Katrin Bondulich, et al.
Published: (2021-03-01)

Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
by: Elisabeth A. Spronck, et al.
Published: (2021-01-01)

The Huntington's disease-related cardiomyopathy prevents a hypertrophic response in the R6/2 mouse model.
by: Michal Mielcarek, et al.
Published: (2014-01-01)

Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
by: Bardile, Costanza Ferrari, et al.
Published: (2020)

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons
by: Florian Krach, et al.
Published: (2022-11-01)

Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease.
by: Lara Moumné, et al.
Published: (2012-01-01)

Understanding Huntington's Disease pathogenesis using next generation sequencing analyses
by: Wasylenko, Theresa Anne
Published: (2016)

SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.
by: Raffaella Tulino, et al.
Published: (2016-01-01)

Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
by: Cesar L. Moreno, et al.
Published: (2016-01-01)

Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.
by: Raffaella Tulino, et al.
Published: (2016-01-01)

Huntington's Disease: Can Mice Lead the Way to Treatment?
by: Crook, Zachary Ryan, et al.
Published: (2014)

Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
by: Elsa C. Kuijper, et al.
Published: (2024-01-01)

Atypical course of Parkinson’s disease with clinical manifestations of Huntington’s disease in a patient with an allele of 27 CAG repeats in the HTT gene
by: M. A. Nikitina, et al.
Published: (2021-01-01)

Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington’s disease
by: Joseph A. White, et al.
Published: (2020-07-01)

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
by: Elisabeth A. Spronck, et al.
Published: (2019-06-01)

Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
by: S. M. Ayala Mariscal, et al.
Published: (2022-08-01)

Targeting H3K4 trimethylation in Huntington disease
by: Ng, Christopher W., et al.
Published: (2014)

Generation of an induced pluripotent stem cell line from a Huntington’s disease patient with a long HTT-PolyQ sequence
by: Duncan C. Miller, et al.
Published: (2023-04-01)

Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.
by: Sydney R Coffey, et al.
Published: (2017-01-01)

Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families
by: Thays A. Apolinário, et al.
Published: (2020-04-01)

Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.
by: Zubeyde Bayram-Weston, et al.
Published: (2016-01-01)

Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study.
by: Nikisha Carty, et al.
Published: (2015-01-01)

Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice
by: Crook, Zachary Ryan, et al.
Published: (2012)